Bone marrow mesenchymal stem cells and liver regeneration: believe the hypoxia!

por Garg, Abhilok, Newsome, Philip N
Publicado 2013

Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?

por Owen, Andrew, Newsome, Philip N.
Publicado 2015

A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells

por Khan, Reenam S., Newsome, Philip N.
Publicado 2019

Mesenchymal Stromal Cells, a New Player in Reducing Complications From Liver Transplantation?

por Owen, Andrew, Newsome, Philip N.
Publicado 2020

Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo

por Shepherd, Emma L, Karim, Sumera, Newsome, Philip N, Lalor, Patricia F
Publicado 2020

PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury

por Owen, Andrew, Patten, Daniel, Vigneswara, Vasanthy, Frampton, Jon, Newsome, Philip N
Publicado 2022

Pretreatment of Mesenchymal Stem Cells Manipulates Their Vasculoprotective Potential While Not Altering Their Homing Within the Injured Gut

por Kavanagh, Dean P.J., Suresh, Shankar, Newsome, Philip N., Frampton, Jon, Kalia, Neena
Publicado 2015

UK experience of liver transplantation for erythropoietic protoporphyria

por Dowman, Joanna K., Gunson, Briget K., Mirza, Darius F., Badminton, Mike N., Newsome, Philip N.
Publicado 2011

Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol

por Than, Nwe Ni, Tomlinson, Claire L., Haldar, Debashis, King, Andrew L., Moore, David, Newsome, Philip N.
Publicado 2016

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

por Boettler, Tobias, Newsome, Philip N., Mondelli, Mario U., Maticic, Mojca, Cordero, Elisa, Cornberg, Markus, Berg, Thomas
Publicado 2020

Changes in human hepatic metabolism in steatosis and cirrhosis

por Schofield, Zoe, Reed, Michelle AC, Newsome, Philip N, Adams, David H, Günther, Ulrich L, Lalor, Patricia F
Publicado 2017

Severe neurological crisis in adult patients with Tyrosinemia type 1

por Dawson, Charlotte, Ramachandran, Radha, Safdar, Samreen, Murphy, Elaine, Swayne, Orlando, Katz, Jonathan, Newsome, Philip N., Geberhiwot, Tarekegn
Publicado 2020

Liver Transplantation for Acute Intermittent Porphyria is Complicated by a High Rate of Hepatic Artery Thrombosis

por Dowman, Joanna K, Gunson, Bridget K, Mirza, Darius F, Bramhall, Simon R, Badminton, Mike N, Newsome, Philip N
Publicado 2012

Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

por Aiyegbusi, Olalekan Lee, di Ruffano, Lavinia Ferrante, Retzer, Ameeta, Newsome, Philip N., Buckley, Christopher D., Calvert, Melanie J.
Publicado 2022

Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity

por Newsome, Philip, Francque, Sven, Harrison, Stephen, Ratziu, Vlad, Van Gaal, Luc, Calanna, Salvatore, Hansen, Morten, Linder, Martin, Sanyal, Arun
Publicado 2019

Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammator...

por Climax, John, Newsome, Philip N., Hamza, Moayed, Weissbach, Markus, Coughlan, David, Sattar, Naveed, McGuire, Darren K., Bhatt, Deepak L.
Publicado 2020

Patient and public perspectives on cell and gene therapies: a systematic review

por Aiyegbusi, Olalekan Lee, Macpherson, Karen, Elston, Lauren, Myles, Susan, Washington, Jennifer, Sungum, Nisha, Briggs, Mark, Newsome, Philip N., Calvert, Melanie J.
Publicado 2020

TGFβ(1) priming enhances CXCR3‐mediated mesenchymal stromal cell engraftment to the liver and enhances anti‐inflammatory efficacy

por Garg, Abhilok, Khan, Sheeba, Luu, N., Nicholas, Davies J., Day, Victoria, King, Andrew L., Fear, Janine, Lalor, Patricia F., Newsome, Philip N.
Publicado 2023

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

por Boettler, Tobias, Marjot, Thomas, Newsome, Philip N., Mondelli, Mario U., Maticic, Mojca, Cordero, Elisa, Jalan, Rajiv, Moreau, Richard, Cornberg, Markus, Berg, Thomas
Publicado 2020

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

por Newsome, Philip N., Sanyal, Arun J., Neff, Guy, Schattenberg, Jörn M., Ratziu, Vlad, Ertle, Judith, Link, Jasmin, Mackie, Alison, Schoelch, Corinna, Lawitz, Eric
Publicado 2023